PMID: 15374259Jan 1, 1995Paper

Long-term therapy of patients with heart failure. Drug therapy: from trial results to clinical practice

Archives of Gerontology and Geriatrics
L QuattriniE Paciaroni

Abstract

Heart failure (HF) represents a major problem in Western countries due to its high prevalence, frequent need for hospitalization and extremely severe prognosis. There have been remarkable advances in long-term drug therapy. During the last decade, the use of vasodilatators, in particular of angiotensin-converting enzyme (ACE)-inhibitors, has been added to the traditional therapy based on diuretics and digitalis. There have been several controlled clinical trials demonstrating the long-term benefits of these drugs for survival. ACE-inhibitors have reduced the risk of mortality in HF, not only by their systemic vasodilatator action but also by their positive effects on ventricular remodelling. In fact, their use has led to a reduction in the incidence of sudden death, and progression of pump dysfunction. A reduction in the incidence of coronary events was also observed. ACE-inhibitors, in combination with diuretics and digitalis, have been rightfully introduced into long-term therapy of HF. At present, other pharmacological options, like flosequinan, some beta-blockers, and some calcium antagonists such as felodipine and amlodipine, hold promise, but further controlled trials are required before they can be introduced into the th...Continue Reading

References

Oct 1, 1975·British Heart Journal·F WaagsteinI Wallentin
May 1, 1992·The American Journal of Medicine·E J Eichhorn
Mar 10, 1991·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·H Yasuda
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Dec 1, 1988·American Heart Journal·G S FrancisJ N Cohn
Apr 15, 1988·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·G W Moe, P W Armstrong
Jul 1, 1988·Annals of Internal Medicine·P R MarantzJ N Tobin
Aug 1, 1980·British Heart Journal·K SwedbergI Wallentin
Sep 1, 1984·Annals of Internal Medicine·G S FrancisJ N Cohn
Aug 1, 1982·The American Journal of Cardiology·Y YuiT Murakami
Dec 1, 1993·Circulation·P W Armstrong, G W Moe
Mar 20, 1993·Lancet·D B Barnett
Oct 1, 1993·Journal of the American College of Cardiology·J N Cohn
Oct 1, 1993·Journal of the American College of Cardiology·R GargS Yusuf

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
C ColinY Matillon
The Yale Journal of Biology and Medicine
R B FetterR E Mills
© 2021 Meta ULC. All rights reserved